In vitro generation of bacillus Calmette-Guérin-activated killer cells.
暂无分享,去创建一个
M. Ernst | H. Flad | A. Ulmer | A. Böhle | S. Brandau | T. Mattern | A. Thanhäuser
[1] Dirk Lorenzen,et al. Phenotypical and functional characterization of Fey receptor I (CD64)‐negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity , 1993, European journal of immunology.
[2] W. Catalona,et al. T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. , 1993, The Journal of urology.
[3] S. Prescott,et al. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. , 1992, The Journal of urology.
[4] R. Pollock,et al. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes. , 1991, Lymphokine and cytokine research.
[5] H. Flad,et al. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines. , 1991, Immunology letters.
[6] J. Smyth,et al. Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. , 1990, The Journal of urology.
[7] J. Gerdes,et al. Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. , 1990, The Journal of urology.
[8] J. Gerdes,et al. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. , 1990, The Journal of urology.
[9] M. Schlaak,et al. Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive modes of monocyte-mediated growth control. , 1990, Experimental cell research.
[10] R. Finberg,et al. Human γδ+ T cells respond to mycobacterial heat-shock protein , 1989, Nature.
[11] W. Catalona,et al. Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. , 1987, The Journal of urology.
[12] W. Catalona,et al. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. , 1986, The Journal of urology.
[13] J. Ortaldo,et al. Lymphokine-activated killer cells. Analysis of progenitors and effectors , 1986, The Journal of experimental medicine.
[14] M. Ernst,et al. Dissociation of responses measured by natural cytotoxicity and chemiluminescence , 1984, European journal of immunology.
[15] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.
[16] W. Leibold,et al. 75Se-release: a short and long term assay system for cellular cytoxicity. , 1979, Zeitschrift fur Immunitatsforschung. Immunobiology.
[17] N. Axelsen,et al. Antibody response in rabbits to immunization with Mycobacterium leprae , 1977, Infection and immunity.
[18] Elizabeth Simpson,et al. A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.